Hybribio secures five new invention patents in key biotech areas

Guangdong Hybribio Biotech Co., Ltd. and its subsidiaries announced on October 10, 2025, the authorization of five new invention patents obtained in September 2025. These patents cover advancements in PCR technology, cell sorting, gene detection, and temperature control systems. Notably, one patent focuses on a real-time fluorescent PCR anti-pollution device and method, contributing to enhanced safety and efficiency in PCR operations. Another patent details a microfluidic chip for cell sorting, optimizing the process of isolating target cells.

Further strengthening their position in genetic testing, the company secured a patent for a multiplex PCR primer and probe composition and kit. This innovation, developed in collaboration with Jinan University, offers a visual detection method for 19 alpha-globin gene variations associated with alpha-thalassemia, improving screening and diagnosis. Additionally, two patents address temperature control systems: one for a fuzzy PID temperature control system and another for a time-sequenced temperature-controlled multi-gene locus detection method and system, both aimed at enhancing precision and stability in various biotech applications.

The acquisition of these invention patents aligns with Hybribio's strategic goal of becoming a leading nucleic acid molecular diagnostic enterprise. While the company stated that these patents would not significantly impact current operations, they are expected to enrich its intellectual property system, strengthen competitive advantages, and expand its product offerings to meet diverse market demands.